Crux Biomedical

About:

Crux Biomedical is a biotech company focused on developing solutions for the clinical limitations of current vena cava filters.

Website: http://www.cruxbiomedical.com

Top Investors: Hercules Capital, Alloy Ventures, Three Arch Partners, Emergent Medical Partners, Thomas Fogarty

Description:

Crux Biomedical, Inc., was formed in August 2004 by physicians Tom Fogarty and Frank Arko based upon their observations of the clinical limitations of current vena cava filters.

Total Funding Amount:

$24.1M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2004-08-01

Contact Email:

info(AT)cruxbiomedical.com

Founders:

Tom Fogarty

Number of Employees:

5001-10000

Last Funding Date:

2011-06-07

IPO Status:

Private

Industries: